Certain molds produce toxic chemicals called mycotoxins that are established causes of cancer in humans, but the route of exposure matters enormously. The strongest and most direct evidence connects dietary exposure to aflatoxins, produced by Aspergillus molds that contaminate grain and nuts, with liver cancer. Breathing in mold spores from a damp basement, by contrast, has not been shown to cause cancer at the concentrations people typically encounter indoors. The gap between those two realities is where most confusion lives.
Aflatoxins and Liver Cancer
The most thoroughly studied link between mold and cancer involves aflatoxin B1, a compound produced by Aspergillus flavus and Aspergillus parasiticus. These molds grow on crops like corn, peanuts, and tree nuts, especially in warm, humid climates. When people eat contaminated food over months or years, aflatoxin B1 gets metabolized in the liver by enzymes that convert it into a reactive form capable of latching onto DNA. This DNA damage targets the p53 gene, a critical tumor suppressor that normally helps prevent cells from becoming cancerous. Laboratory studies using human liver cell lines have shown that specific liver enzymes activate aflatoxin B1 and produce characteristic DNA damage, including mutations at a particular spot on p53 known as codon 249, which is a signature mutation found in liver tumors from aflatoxin-exposed populations.1Carcinogenesis. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
The International Agency for Research on Cancer (IARC) classifies naturally occurring mixtures of aflatoxins as Group 1 carcinogens, meaning there is sufficient evidence that they cause cancer in humans. A systematic review of epidemiological studies found clear dose-dependent relationships between aflatoxin exposure and liver cancer risk, consistent with IARC’s conclusions.2PubMed. Mycotoxin exposure and human cancer risk: A systematic review of epidemiological studies This is not a marginal or uncertain finding. Aflatoxins are among the most potent natural carcinogens known.
Why Hepatitis B Makes Aflatoxin Far More Dangerous
Aflatoxin exposure alone raises liver cancer risk, but when a person also carries chronic hepatitis B virus (HBV), the two risk factors do not simply add together. They multiply. A meta-analysis estimated that the combined odds ratio for people exposed to both aflatoxin and chronic HBV infection was roughly 73, compared to about 6 for aflatoxin alone and about 11 for HBV alone.3PubMed Central. Population Attributable Risk of Aflatoxin-Related Liver Cancer: Systematic Review and Meta-Analysis That is a nearly perfect multiplicative interaction, meaning a person with both exposures faces a cancer risk far greater than either risk factor would suggest on its own.
Researchers have identified molecular mechanisms that explain this synergy. The hepatitis B X protein appears to enhance the liver’s activation of aflatoxin B1 through a signaling pathway that increases the toxicity of the mycotoxin.4PubMed Central. Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis The virus essentially primes the liver to be more vulnerable to the mycotoxin’s DNA-damaging effects.5PubMed. Synergism in actions of HBV with aflatoxin in cancer development This matters most in parts of sub-Saharan Africa and Southeast Asia where both HBV infection rates and dietary aflatoxin exposure are high. It also explains why liver cancer rates in these regions have historically been strikingly higher than in industrialized countries with lower aflatoxin contamination and widespread hepatitis B vaccination.
Other Mycotoxins Linked to Cancer
Aflatoxins get the most attention, but other mold-produced toxins have also raised cancer concerns, with varying levels of evidence.
Fumonisins and Esophageal Cancer
Fumonisins, especially fumonisin B1, are produced by Fusarium molds that commonly infect corn. Populations in parts of China, Iran, and southern Africa that consume large amounts of corn have shown correlations between fumonisin contamination and esophageal cancer rates. In northeastern China, fumonisin contamination in corn from high-risk esophageal cancer areas was roughly twice as frequent as in low-risk areas.6PubMed Central. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China A study in Iran’s Golestan province similarly found high levels of fumonisin B1 in rice samples, with a significant positive relationship between contamination levels and esophageal cancer risk.7PubMed. Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran IARC classifies fumonisin B1 as Group 2B, meaning “possibly carcinogenic to humans.” The evidence is suggestive but not as airtight as for aflatoxins, partly because esophageal cancer has many overlapping risk factors in these populations, including smoking and nutritional deficiencies.
Ochratoxin A and Kidney Disease
Ochratoxin A (OTA) is produced by Aspergillus and Penicillium species that contaminate cereals, wine, coffee, and dried fruits. It causes kidney tumors in rodents and has long been suspected of playing a role in Balkan endemic nephropathy, a devastating kidney disease found in parts of southeastern Europe that co-occurs with unusually high rates of urothelial tumors of the renal pelvis and ureters.8PubMed. Ochratoxin A in human kidney diseases However, the evidence is contested. Some researchers have pointed out that the kidney lesions seen in OTA-treated rats look quite different from the pathology of Balkan endemic nephropathy, and that human dietary OTA exposure, even in endemic areas, appears to be far below the doses that cause tumors in lab animals.9PubMed. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats IARC classifies OTA as Group 2B, the same “possibly carcinogenic” category as fumonisins. The debate is unresolved, and recent investigations have explored the possibility that aristolochic acid from a plant consumed in the Balkans may be a more likely culprit for the kidney disease than OTA.
Sterigmatocystin
Sterigmatocystin is a mycotoxin produced by several Aspergillus species and is actually a precursor chemical to aflatoxin B1. It affects multiple crop types and causes tumors in laboratory animals. IARC classifies it in Group 2B as well. It is less commonly encountered in food at dangerous levels than aflatoxins, but its structural similarity to aflatoxin has kept it on the radar for food safety monitoring.
What About Indoor Mold and Cancer?
This is the question most people actually want answered. You discover mold in your bathroom, your basement floods, or you notice a musty smell in your apartment. Should you be worried about cancer? Based on current evidence, the answer is that indoor mold exposure at the concentrations typically found in homes does not appear to cause cancer. A critical review of health effects from mycotoxins in indoor air found that while high-level exposures could produce health effects, the literature does not support the idea that exposure at levels found in most mold-contaminated indoor environments is likely to cause measurable harm.
This disconnect surprises people, because the same chemicals that cause cancer through dietary intake are, in theory, present on mold growing indoors. But dose makes the poison. Eating grain contaminated with aflatoxin delivers the toxin directly to the digestive system and liver in quantities that can accumulate over years of chronic exposure. Breathing air in a moldy building typically delivers far lower doses and through a completely different route. Your lungs handle small inhaled particles differently than your gut handles contaminated food, and the concentrations of airborne mycotoxins in even very moldy homes are generally orders of magnitude below the levels associated with cancer in dietary studies.
A large occupational study following Finnish workers with high occupational exposure to molds and bacteria actually found a reduced risk of lung cancer among the most heavily exposed men, with a relative risk of about 0.7 for mold exposure. The authors noted that endotoxins from bacterial co-exposure might have a protective effect. Overall, the study found that mold and bacterial exposures at occupational concentrations were unlikely to be major cancer risk factors.10PubMed. Moulds, bacteria and cancer among Finns: an occupational cohort study That does not mean mold is harmless. Indoor mold triggers asthma attacks, worsens allergies, and causes respiratory irritation. These are real problems worth addressing. They are just not cancer.
The Myth of Toxic Mold Syndrome
Part of the confusion around mold and cancer stems from the broader “toxic mold” narrative that has entered public consciousness. The concept of toxic mold syndrome, in which indoor mold exposure is blamed for a wide range of chronic conditions including autoimmune diseases and neurological symptoms, has been examined and found wanting by multiple medical reviews. As one review in a clinical immunology journal put it bluntly, there is no evidence that airborne mycotoxin levels in indoor environments are sufficient to cause any disease known to medicine, and mycotoxins have been falsely associated with autoimmune diseases and various other conditions. Indoor mold is a respiratory irritant and allergen, but the leap to systemic illness or cancer from normal indoor exposure is not supported by the science.
This matters because fear of “toxic mold” drives some homeowners to spend thousands of dollars on questionable mold testing and remediation services marketed with cancer-scare language. If you have visible mold in your home, clean it up and fix the moisture problem that caused it. Do this because mold damages your home and triggers respiratory symptoms, not because you are at risk of developing cancer from your shower tiles.
How Mycotoxins Damage Cells
The cancer-causing mycotoxins share some common strategies for damaging cells, though the details vary by toxin. Aflatoxin B1 is the most direct actor. After the liver converts it into its reactive form, it physically attaches to DNA, forming adducts that cause specific mutations. This is classic genotoxicity, the kind of direct DNA damage that can initiate cancer if it hits the wrong gene.
Other mycotoxins appear to work more indirectly through oxidative stress. Deoxynivalenol, a Fusarium toxin common in wheat and barley, causes DNA strand breaks in liver cells, and this damage can be almost completely prevented by antioxidant pre-treatment, strongly suggesting that reactive oxygen species are the actual culprits doing the damage rather than the toxin itself hitting DNA directly.11PubMed. The role of oxidative stress in deoxynivalenol-induced DNA damage in HepG2 cells Similarly, ochratoxin A appears to cause oxidative DNA damage rather than binding to DNA directly, leading researchers to conclude that it likely acts through an indirect, threshold-based mechanism rather than as a classical direct carcinogen.12Mutagenesis. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity The distinction is practically important because a threshold-based mechanism implies there is some level of exposure below which no cancer risk occurs, while direct DNA damage has no theoretical safe threshold.
Beyond direct DNA damage, mycotoxins can also alter gene expression through epigenetic changes. Aflatoxins have been shown to promote liver cancer cell growth through DNA methylation changes, modifications to histone proteins, and disruption of non-coding RNA regulation.13Liver Cancer International. Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinoma Fusarium mycotoxins also trigger epigenetic modifications implicated in carcinogenesis and reproductive toxicity.14PubMed. The epigenetic mechanisms in Fusarium mycotoxins induced toxicities These epigenetic effects do not change the DNA sequence itself but can switch genes on or off in ways that favor tumor development. Research in this area is still evolving, but it adds another layer to understanding how chronic mycotoxin exposure nudges cells toward malignancy.
A Prevention Success Story
Perhaps the most compelling evidence for the aflatoxin-cancer link comes not from laboratory studies but from watching what happens when exposure drops. In Qidong, a region in eastern China that historically had some of the world’s highest liver cancer rates, a natural experiment played out starting in the 1980s. Economic reforms shifted the local diet from heavily aflatoxin-contaminated corn to minimally contaminated rice. Using a cancer registry established in 1972 and aflatoxin-specific biomarkers, researchers documented a nearly 70% decline in age-standardized liver cancer incidence over 30 years, even though the prevalence of hepatitis B infection in cancer cases did not change.15PubMed Central. Profound primary prevention of liver cancer following a natural experiment in China: A 50-year perspective and public health implications The decline tracked the reduction in aflatoxin exposure with striking consistency.
On the viral side, hepatitis B vaccination programs also reduce liver cancer risk in aflatoxin-exposed populations by removing the multiplicative synergy between the two risk factors.16PubMed. Aflatoxin, hepatitis and worldwide liver cancer risks Combining vaccination with aflatoxin reduction is expected to have a major impact on global liver cancer burden.17Gastroenterology. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas More than 70 countries have established regulatory limits on mycotoxin levels in food, though the specific limits vary widely.18TrAC Trends in Analytical Chemistry. Validation of analytical methods for determining mycotoxins in foodstuffs In Europe and North America, testing and regulation keep aflatoxin levels in commercially sold food well below the exposures seen in historical studies. The people at greatest risk today live in regions where food storage infrastructure is limited, grain is stored in humid conditions, and regulatory enforcement is weak.
Your Gut Bacteria and Mycotoxin Processing
An emerging area of research involves the gut microbiome’s role in determining how harmful ingested mycotoxins actually are. Your gut bacteria can chemically modify mycotoxins before they are absorbed. In some cases, this is protective: certain microbes break down mycotoxins into less toxic forms or physically bind them so they pass through without being absorbed. This discovery has led to the development of probiotic products and enzyme preparations used in animal farming to reduce mycotoxin toxicity in livestock feed.19PubMed Central. Mycotoxin and Gut Microbiota Interactions
The relationship is not always beneficial, though. Some gut bacteria can activate “masked” mycotoxins, chemically modified forms of mycotoxins that plants produce as a defense mechanism. These masked forms are less toxic in their modified state, but gut bacteria can strip away the modifications and release the active toxin. Whether the microbiome helps or hurts depends on which mycotoxin is involved and which bacteria are present, which partly explains why different species and even different individuals show varying susceptibility to the same mycotoxin exposure.20Frontiers in Nutrition. Microbiome–mycotoxin interactions and probiotic strategies: implications for gut health and cancer Whether probiotic interventions could meaningfully reduce cancer risk from mycotoxins in humans remains an open question, and clinical trials are still lacking. But the concept that your individual gut ecology influences how much damage a given mycotoxin exposure can do is well established in animal research and increasingly being explored in humans.